Symposium 2014 Program

Welcome

Opening remarks

Raymond Lai, MD, PhD, FRCP (Medical Director, DynaLIFE)

Laboratory system in Alberta

Jason Pincock, CMA (CEO, DynaLIFE)


Annual Periodic Health Exam Topics

Colorectal cancer screening: Updates & fecal immunoassay test (FIT) 

Mathew Estey, PhD and Vilte Barakauskas, PhD

Screening for cervical cancer: Updates 

Gordon Johnson, MD, FRCPC


Common Clinical Challenges

Cardiac troponins: Becoming a lousy test? 

Karina Capote, MD, PhD, FCACB

Common abnormal ECG rhythms you will be glad to know! 

Joel Allen, MD

Approach to anemia 

Stuart Brown, MD, FRCPC


Stewardship & Diagnostic Utilization Challenges

Utilizing the microbiology laboratory to achieve optimal patient care 

Shobhana Kulkarni, MBBS, MSc, FRCPath

Sore throat: Do you really need antibiotics? 

Natalia Solomon, MD, FRCPC

When are test results significantly different? 

Trefor Higgins, MSc, FCACB

 


 

Due to technical difficulties, audio is not available for the presentations.

Symposium 2014 Speaker Biographies

 

Raymond Lai, MD, FRCPC, Medical Director(raymond.lai@dynalifedx.com)

Dr. Raymond Lai took on the role of medical director at DynaLIFE in November 2010. Dr. Lai obtained his MD and PhD degrees and completed his general pathology residency training at the University of Alberta. He then completed a hematopathology fellowship at the City of Hope National Medical Center in Duarte, California. Dr. Lai also runs an active research laboratory at the University of Alberta.

Jason Pincock, CMA, Chief Executive Officer(jason.pincock@dynalifedx.com)
Mr. Jason Pincock has been with DynaLIFE since its inception in 1996. Jason has spent the last eight years working closely with executives within government and industry to structure and support new and innovative service models for healthcare. Jason is a certified management accountant, a graduate of the Queens Executive Program and a member of the Institute of Corporate Directors.

Mathew Estey, PhD (mathew.estey@dynalifedx.com)

Dr. Mathew Estey obtained a PhD in biochemistry and cell biology from the University of Toronto in 2011. His research focused on elucidating the function of a protein called Septin9, which has been implicated in certain types of cancer. In recognition of this work, he received the Hospital for Sick Children’s Exceptional Trainee Award for research excellence and exemplary characteristics. Dr. Estey then completed a postdoctoral fellowship in clinical chemistry, also at the University of Toronto. During this time, he was the lead investigator of the CALIPER transference study, a Canada-wide initiative to determine age and gender specific pediatric reference intervals. Areas of clinical and research expertise: Celiac disease, cobalt/chromium toxicity, endrocrinology, hemoglobinopathies and pediatric reference intervals.

Vilte Barakauskas, PhD (vilte.barakauskas@dynalifedx.com)

Dr. Barakauskas completed doctoral training in neuroscience at the University of British Columbia and a postdoctoral fellowship in clinical chemistry at the University of Utah/ARUP Laboratories. She has clinical laboratory experience in both reference laboratory and hospital settings and holds certification from the American Board of Clinical Chemistry. Vilte has been involved in undergraduate, resident and continuing medical education and curriculum development, and has a strong interest in teaching and learning. Clinical and research interest/expertise: Celiac disease, alpha-1-antitrypsin deficiency, laboratory process improvement, analytical method development and mass spectrometry.

 

Gordon Johnson, MD, FRCPC (gordon.johnson@dynalifedx.com)

Dr. Gordon Johnson completed his undergraduate education, medical school and a residency in general pathology all at the University of Alberta. Dr. Johnson has been the director of cytology at DynaLIFE for many years and is a leader in the Cervical Cancer Screening Program of Alberta. He has also long served as the consultant pathologist to the Alberta Laboratory Quality Improvement Program of the College of Physicians and Surgeons of Alberta. Areas of clinical and research expertise: Gynecologic and non-gynecologic cytology.

Karina Capote, MD, PhD, FCAB (karina.capote@dynalifedx.com)
Dr. Karina Capote obtained her MD from the Instituito de Ciencias M├ędicas de la Habana (Higher Institute of Medical Sciences) in Havana, Cuba in 1993. She then completed a first degree specialization in clinical biochemistry at the Basic and Preclinical Sciences Institute of Medical Sciences, also in Havana. After immigrating to Canada, Dr. Capote completed a postdoctoral fellowship with the department of obstetrics and gynecology at the London Health Sciences Centre and University of Western Ontario in London. ON and obtained a PhD in biochemistry from the University of Western Ontario. Dr. Capote held the Kilee Patchell-Evans postdoctoral fellowship in nueorscience with the Autism Research Group and the Department of Psychology and Neuroscience from 2005-006 at the University of Western Ontario in London, ON. She completed her certification in clinical chemistry with the Canadian Academy of Clinical Biochemistry in 2010. Areas of clinical and research expertise: allergy and celiac disease serology, hemoglobinopathies, immunology, evidence based medicine, education, test utilization, method development, quality assurance and quality management.

Joel Allen, MD

Dr. Joel Allen is a member of the DynaLIFE ECG interpretation panel.

 

Stuart Brown, MD, FRCPC (stuart.brown@dynalifedx.com)

Dr. Stuart Brown obtained his medical degree at the University of Manitoba. He completed his residency in general pathology at the University of British Columbia, followed by a fellowship in hematopathology at Vancouver General Hospital. Dr. Brown is currently the director of hematology at DynaLIFE. In his spare time he enjoys playing recreational hockey and spending time with his family. Areas of clinical and research expertise: hematopathology.

Shobhana Kulkarni, MBBS, MSc, FRCPath, FRCPC(shobhana.kulkarni@dynalifedx.com)

Dr. Shobhana Kulkarni is a medical microbiologist who has been working at DynaLIFE since 2007. She previously trained and worked in London, England. She has an interest in promoting antimicrobial stewardship and microbiology test utilization.

Natlie Solomon, MD (natalia.solomon@dynalifedx.com)

Dr. Natalia Solomon completed a fellowship in pediatric infectious diseases in 2005 and residency training in medical microbiology in 2009 at the University of Alberta. After graduation she worked as a full time medical microbiologist at the Provincial Laboratory for Public Health and the University of Alberta Hospitals microbiology laboratory, where she gained experience in acute care microbiology, community microbiology, virology, infection control and public health aspects of laboratory services. Dr. Solomon has a strong interest in medical education. She served for four years as the program director for the medical microbiology residency program at the University of Alberta and she continues to be involved with undergraduate and postgraduate medical education. Areas of clinical and research expertise: Bacteriology, mechanisms of antimicrobial resistance, pediatric microbiology and prenatal testing.

Trefor Higgins, MSc, FCACB (trefor.higgins@dynalifedx.com)
Mr. Trefor Higgins completed his undergraduate degree in education in the United Kingdom and then moved to Edmonton and the University of Alberta where he completed his masters of science degree. In 2005, Mr. Higgins was awarded a Fellowship by Special Distinction by the Canadian Academy of Clinical Biochemistry. This was the first time this fellowship was ever awarded. Mr. Higgins is currently the director of clinical chemistry at DynaLIFE and has many years of experience in the position. Areas of clinical and research expertise: HbA1c, hemoglobinopathies and thalassemias.